###begin article-title 0
###xml 109 110 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 114 115 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Angiogenesis in Differentiated Placental Multipotent Mesenchymal Stromal Cells Is Dependent on Integrin alpha5beta1
###end article-title 0
###begin p 1
Conceived and designed the experiments: CPC. Performed the experiments: MYL YHW CYC PCC. Analyzed the data: MYL JPH YYC JDA CPC. Contributed reagents/materials/analysis tools: JPH YYC CPC. Wrote the paper: MYL CPC.
###end p 1
###begin p 2
###xml 224 225 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 232 233 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 240 241 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 247 248 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 254 255 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 265 266 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 389 390 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 399 400 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 415 416 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 423 424 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 428 429 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 439 440 396 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 444 445 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 643 644 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 648 649 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 664 665 607 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 669 670 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 679 680 615 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 684 685 617 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 844 845 773 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 854 855 780 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1337 1338 1259 1260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1347 1348 1266 1267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1524 1525 1439 1440 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1529 1530 1441 1442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 886 891 <span type="species:ncbi:9031">chick</span>
###xml 925 930 <span type="species:ncbi:9606">human</span>
###xml 1000 1005 <span type="species:ncbi:9031">chick</span>
###xml 1107 1112 <span type="species:ncbi:9606">human</span>
Human placental multipotent mesenchymal stromal cells (hPMSCs) can be isolated from term placenta, but their angiogenic ability and the regulatory pathways involved are not known. hPMSCs were shown to express integrins alphav, alpha4, alpha5, beta1, beta3, and beta5 and could be induced to differentiate into cells expressing endothelial markers. Increases in cell surface integrins alpha5 and beta1, but not alpha4, alphavbeta3, or alphavbeta5, accompanied endothelial differentiation. Vascular endothelial growth factor-A augmented the effect of fibronectin in enhancing adhesion and migration of differentiated hPMSC through integrin alpha5beta1, but not alphavbeta3 or alphavbeta5. Formation of capillary-like structures in vitro from differentiated cells was inhibited by pre-treatment with function-blocking antibodies to integrins alpha5 and beta1. When hPMSCs were seeded onto chick chorioallantoic membranes (CAM), human von Willebrand factor-positive cells were observed to engraft in the chick endothelium. CAMs transplanted with differentiated hPMSCs had a greater number of vessels containing human cells and more incorporated cells per vessel compared to CAMs transplanted with undifferentiated hPMSCs, and overall angiogenesis was enhanced more by the differentiated cells. Function-blocking antibodies to integrins alpha5 and beta1 inhibited angiogenesis in the CAM assay. These results suggest that differentiated hPMSCs may contribute to blood vessel formation, and this activity depends on integrin alpha5beta1.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Oswald1">[1]</xref>
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Alviano1">[4]</xref>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Fukuchi1">[5]</xref>
###xml 451 454 451 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Yen1">[6]</xref>
###xml 455 458 455 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-PortmannLanz1">[8]</xref>
###xml 608 611 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Wu1">[9]</xref>
###xml 164 169 <span type="species:ncbi:9606">Human</span>
Multipotent mesenchymal stromal cells from different adult and fetal tissues have been shown to have the potential to differentiate into endothelial cells [1]-[4]. Human placental multipotent mesenchymal stromal cells (hPMSCs) express genes associated with ectoderm, endoderm and mesoderm, including hematopoietic/endothelial cell-related transcripts [5]. They can differentiate into osteogenic, adipogenic, chondrogenic, and neurogenic cell lineages [6]-[8], and, under the combined influence of growth factors and mechanical shear stress, have been reported to acquire aspects of the endothelial phenotype [9]. However, the angiogenic ability of these cells is not well characterized.
###end p 4
###begin p 5
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Breier1">[10]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Williams1">[11]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-vanderLoo1">[12]</xref>
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Wijelath1">[13]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Wijelath2">[14]</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Yang1">[15]</xref>
###xml 741 745 741 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Francis1">[18]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Astrof1">[19]</xref>
###xml 1019 1023 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Chen1">[20]</xref>
###xml 722 728 <span type="species:ncbi:10090">murine</span>
###xml 960 965 <span type="species:ncbi:9606">human</span>
Angiogenesis is a complex process that involves extracellular matrix (ECM) remodeling, endothelial cell differentiation, migration and proliferation, and the functional maturation of new endothelial cell colonies into mature blood vessels [10]. There is evidence that fibronectin is a key ECM component at several stages, initially providing attachment sites for precursor cells [11], [12], then promoting vascular endothelial growth factor (VEGF)-induced differentiation to endothelial cells [13]. Furthermore, fibronectin associated with VEGF-A enhances endothelial cell migration [14]. Targeted gene deletion studies have revealed that fibronectin functions in vascular stabilization and branching morphogenesis in the murine embryo [15]-[18], while a more restricted gene targeting approach that deletes alternatively spliced variants of fibronectin leads to defective placental angiogenesis [19]. Fibronectin is abundant in the mesenchymal compartment of human placenta where vasculogenesis and angiogenesis occur [20].
###end p 5
###begin p 6
###xml 14 15 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 19 20 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 112 116 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Kim1">[21]</xref>
###xml 132 133 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 137 138 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 222 226 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Muether1">[22]</xref>
###xml 294 298 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Kim1">[21]</xref>
###xml 300 304 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Magnussen1">[23]</xref>
###xml 306 310 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-ParsonsWingerter1">[24]</xref>
###xml 521 525 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Demir1">[25]</xref>
###xml 527 531 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Kaufmann1">[26]</xref>
###xml 640 644 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Chen2">[27]</xref>
###xml 646 650 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Mayhew1">[28]</xref>
###xml 763 767 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-CharnockJones1">[29]</xref>
###xml 699 704 <span type="species:ncbi:9606">human</span>
Integrin alpha5beta1 is a selective high affinity receptor for fibronectin, and a regulator of VEGF-A signaling [21]. Integrin alpha5beta1 is observed to have an essential role in pathological neovascularization in cornea [22] and is up-regulated in newly growing vessels in embryos and tumors [21], [23], [24]. Vascularization in the placenta is critical for normal delivery of nutrients to the fetus. Placental growth is most rapid in the first half of pregnancy, but development of the vascular tree continues to term [25], [26]. Placental vascular defects, including reduced vessel density, are associated with fetal growth restriction [27], [28]. VEGF-A is thought to play an important role in human placental vascularization, especially in the early stages [29].
###end p 6
###begin p 7
###xml 462 463 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 467 468 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Improved understanding of the cellular and molecular mechanisms of placental vasculogenesis and angiogenesis could potentially lead to treatments to achieve improved pregnancy outcome as well as the possibility of using placental progenitor cells in therapeutic applications. Thus, the aims of this study were to investigate if hPMSCs are capable of functional differentiation into endothelial cells, and to investigate the role in this process of integrin alpha5beta1 and its interaction with fibronectin in the presence of VEGF-A.
###end p 7
###begin title 8
Materials and Methods
###end title 8
###begin title 9
Isolation and culture, of placenta-derived cells
###end title 9
###begin p 10
###xml 18 23 <span type="species:ncbi:9606">human</span>
Clinically normal human placentas (37 to 40 weeks of gestation, n = 30) were obtained after cesarean section. Tissue was collected after written informed consent was obtained, and this study was approved by the Institutional Review Board of Mackay Memorial Hospital, Taipei. The animal studies were specifically approved by the ethics committee of Mackay Memorial Hospital for animal experimentation and were conducted following the institution's guidelines for animal husbandry.
###end p 10
###begin p 11
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Chen3">[30]</xref>
###xml 579 583 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Pittenger1">[31]</xref>
###xml 757 758 745 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 678 684 <span type="species:ncbi:9913">bovine</span>
Isolation of hPMSCs was performed as we described previously [30]. Briefly, about 100 g of tissue from central placental cotyledons was minced, trypsinized (0.05% trypsin-EDTA solution; Invitrogen), and treated with 10 U/ml DNase I (Sigma-Aldrich) in Dulbecco's modified Eagle's medium (DMEM; Gibco) at 37degreesC for 5 min several times, and finally filtered through a cell strainer (BD Biosciences). The supernatants were pooled and centrifuged, and the mononuclear cells in the supernatants were recovered by Percoll density gradient fractionation (1.073 g/ml, Sigma-Aldrich) [31]. The cells were resuspended and seeded in a flask, and were maintained in DMEM with 10% fetal bovine serum (FBS; Hyclone) at 37degreesC in a humidified atmosphere with 5% CO2. Approximately 2 to 3 weeks later, some colonies containing fibroblast-like cells were observed. These cells were trypsinized and replated for expansion after 70% confluence.
###end p 11
###begin title 12
Flow cytometry
###end title 12
###begin p 13
###xml 319 321 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
The cell phenotype of hPMSCs was characterized by a panel of PE- or FITC-conjugated antibodies purchased from Serotec, Calbiochem, Chemicon, R&D systems, GeneTex, or BD Biosciences using standard fluorescence-activated cell sorting analysis and CellQuest software. The cells were permeabilized using BD Cytofix/CytopermTM Fixation/Permeabilization Kit (BD) according to the manufacturer's recommendation before flow cytometry assay for Oct-4 (Chemicon).
###end p 13
###begin p 14
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-EghbaliFatourechi1">[32]</xref>
Alterations of integrin abundance on the cell surface of hPMSCs were evaluated by fluorescence intensity, an index of the surface concentration of integrin per cell. Mean fluorescence is the estimated x axis value at maximum peak height. This parameter is measured independently from the proportion of positive cells, estimated as the difference between the mean fluorescence (the surface concentration of integrin molecules) of positive cells and that of the control samples, regardless of the frequency of positive cells [32].
###end p 14
###begin title 15
Reverse-transcription PCR (RT-PCR)
###end title 15
###begin p 16
###xml 70 101 70 101 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGTGAAGCTGGAGAAGGAGAAGCTG-3&#8242;</named-content>
###xml 114 145 114 145 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAAGGGCCGCAGCTTACACATGTTC-3&#8242;</named-content>
###xml 198 227 198 227 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATACCTCAGCCTCCAGCAGATG-3&#8242;</named-content>
###xml 241 270 241 270 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGCGTCACACCATTGCTATTCT-3&#8242;</named-content>
###xml 296 327 296 327 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCAGCTACAGCATGATGCAGGAGC-3&#8242;</named-content>
###xml 340 369 340 369 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGGTCATGGAGTTGTACGCAGG-3&#8242;</named-content>
###xml 383 412 383 412 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GACGTGCTGTTTTACAACATCTC-3&#8242;</named-content>
###xml 425 450 425 450 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTCACGATCCCACCTTGG-3&#8242;</named-content>
###xml 464 490 464 490 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGCTTTGCTTGCTGAGTTT-3&#8242;</named-content>
###xml 503 529 503 529 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCATGTTGAGACACAGGGT-3&#8242;</named-content>
###xml 550 575 550 575 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGAGACCACGCCTCTGTC-3&#8242;</named-content>
###xml 588 612 588 612 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGGCCCTGGGCATCTC-3&#8242;</named-content>
###xml 675 701 675 701 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAAGGCATGAGGATGAGAGC-3&#8242;</named-content>
###xml 714 741 714 741 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGGCTCATGAACTTGAAAGC-3&#8242;</named-content>
###xml 758 786 758 786 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCCAAGTGATTGAAGCAGATG-3&#8242;</named-content>
###xml 799 827 799 827 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCAGATCCACAGGGATTGCTC-3&#8242;</named-content>
###xml 870 897 870 897 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACGTGATCCTTCTCCTGGATG-3&#8242;</named-content>
###xml 910 937 910 937 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCACCACGTTGGAGTCGCCT-3&#8242;</named-content>
###xml 958 985 958 985 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAACATGCAGATCTGGACCAC-3&#8242;</named-content>
###xml 998 1025 998 1025 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTTTAGTACCAGGGTCATGGC-3&#8242;</named-content>
###xml 1038 1066 1038 1066 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAGAGCTAATACATGCCGACGG-3&#8242;</named-content>
###xml 1079 1108 1079 1108 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGCCTCGAAAGAGTCCTGTATT-3&#8242;</named-content>
###xml 1170 1173 1170 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Alviano1">[4]</xref>
###xml 1175 1179 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Beltrami1">[33]</xref>
###xml 1180 1184 1180 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Feistritzer1">[37]</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 829 834 <span type="species:ncbi:9606">human</span>
###xml 939 944 <span type="species:ncbi:9606">human</span>
The following primers were used for PCR reactions: human Oct-4 sense, 5'-CGTGAAGCTGGAGAAGGAGAAGCTG-3'; antisense, 5'-CAAGGGCCGCAGCTTACACATGTTC-3'; homeobox transcription factor nanog (Nanog) sense, 5'-AATACCTCAGCCTCCAGCAGATG-3'; anti-sense, 5'-CTGCGTCACACCATTGCTATTCT-3'; Sry-Box 2 (Sox-2) sense 5'-GGCAGCTACAGCATGATGCAGGAGC-3'; antisense, 5'-CTGGTCATGGAGTTGTACGCAGG-3'; CD31 sense, 5'-GACGTGCTGTTTTACAACATCTC-3'; antisense, 5'-CCTCACGATCCCACCTTGG-3'; CD34 sense, 5'-GCGCTTTGCTTGCTGAGTTT-3'; antisense, 5'-GCCATGTTGAGACACAGGGT-3'; VE-cadherin sense, 5'-GGGAGACCACGCCTCTGTC-3'; antisense, 5'-GGAGGCCCTGGGCATCTC-3'; VEGFR (vascular endothelial growth factor receptor)-1 sense, 5'-GAAGGCATGAGGATGAGAGC-3'; antisense, 5'-CAGGCTCATGAACTTGAAAGC-3'; VEGFR-2 sense, 5'-GGCCAAGTGATTGAAGCAGATG-3'; antisense, 5'-TTCAGATCCACAGGGATTGCTC-3'; human von Willebrand factor (vWF) sense, 5'-ACGTGATCCTTCTCCTGGATG-3'; antisense, 5'-TTCACCACGTTGGAGTCGCCT-3'; human CD105 sense, 5'-CAACATGCAGATCTGGACCAC-3'; antisense, 5'-CTTTAGTACCAGGGTCATGGC-3'; 18S sense, 5'-TAGAGCTAATACATGCCGACGG-3'; antisense, 5'-GGGCCTCGAAAGAGTCCTGTATT-3'. The RT-PCR reactions were performed as previously described [4], [33]-[37].
###end p 16
###begin title 17
Differentiation induction
###end title 17
###begin title 18
Induction of osteogenic or adipogenic differentiation
###end title 18
###begin p 19
###xml 429 432 402 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Alviano1">[4]</xref>
###xml 434 437 407 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Zhang1">[7]</xref>
###xml 768 772 741 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Ishikane1">[38]</xref>
hPMSC cells in passages 6 through 10 (n = 5) were cultured in either osteogenic medium consisting of DMEM containing 10% FBS (Hyclone), 0.1 microM dexamethasone, 10 mM beta-glycerol phosphate, 500 microM ascorbic acid (Sigma-Aldrich) or adipogenic medium consisting of DMEM containing 10% FBS (Hyclone), 1 microM dexamethasone, 500 microM isobutylmethylxanthine, 200 microM indomethacin, and 10 microg/ml insulin (Sigma-Aldrich) [4], [7]. The medium was changed every 3 days. After 2 weeks of culture, the cells were fixed with methanol, stained either with 1% Alizarin Red S (Sigma-Aldrich) to assess calcium phosphate deposition indicating osteogenic differentiation or with Oil Red O (Sigma-Aldrich) to look for lipid droplets indicating adipogenic differentiation [38].
###end p 19
###begin title 20
Induction of endothelial cell differentiation
###end title 20
###begin p 21
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 708 711 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Oswald1">[1]</xref>
###xml 713 716 701 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Alviano1">[4]</xref>
###xml 230 235 <span type="species:ncbi:9606">human</span>
###xml 288 293 <span type="species:ncbi:9606">human</span>
###xml 465 470 <span type="species:ncbi:9606">human</span>
hPMSCs were seeded at a density of 1x103 cells/cm2 in petri dishes and cultured in endothelial cell growth medium 2 (EGM2; Promocell) supplemented with Supplement Mix (Promocell) which contains 1 microg/ml ascorbic acid, 10 ng/ml human recombinant basic fibroblast growth factor, 5 ng/ml human recombinant epidermal growth factor, 22.5 microg/ml heparin, 0.2 microg/ml hydrocortisone, 20 ng/ml long R3 insulin like growth factor-1, 0.62 ng/ml phenol red, 0.5 ng/ml human recombinant VEGF-A, and 2% FBS (Hyclone). Additionally, 50 ng/ml VEGF-A (Chemicon) was added to medium for induction of differentiation. The cultures were maintained for 14 to 21 days and the culture medium was replaced every three days [1], [4].
###end p 21
###begin title 22
Immunofluorescence staining
###end title 22
###begin p 23
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Chen1">[20]</xref>
###xml 358 359 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 393 394 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 426 427 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 459 461 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#957;</sub>
###xml 465 466 446 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 502 504 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#957;</sub>
###xml 508 509 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
Immunofluorescence staining was performed as previously described [20]. Primary antibody against specific proteins included CD31 (JC70A; 1:50; Dako), CD34 (QBEND/10; 1:100; Serotec), VE-cadherin (BV6; 1:100; Chemicon), vWF (1:200; Sigma-Aldrich), CD105 (SN6h; 1:50; Dako), VEGFR-1 (Flt-1/EWC; 1:1000; abcam), VEGFR-2 (89106; 1:50; R&D Systems), integrin beta1 (HUTS-4; 1:1000; Chemicon), alpha4 (P4G9; 1:1000; Chemicon), alpha5 (SAM-1; 1:100; Chemicon), alphanubeta3 (LM609; 1:100; Chemicon), and alphanubeta5 (P1F6; 1:1000; Chemicon). Antibodies were diluted as appropriate in 1% BSA in PBS. 4', 6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) was used to identify nuclei.
###end p 23
###begin title 24
Adhesion assay
###end title 24
###begin p 25
###xml 494 495 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 529 530 502 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 562 563 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 595 597 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#957;</sub>
###xml 601 602 562 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 637 639 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#957;</sub>
###xml 643 644 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 686 687 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
###xml 434 439 <span type="species:ncbi:10090">mouse</span>
The 24-well plates were coated with 10 microg/ml human fibronectin (Upstate), vitronectin (Upstate), or 2.5% BSA (as a control) at 37degreesC for one hour. After washing with PBS, the wells were blocked with 2.5% (wt/vol) BSA in PBS at room temperature for one hour. VEGF-A induced differentiated hPMSCs were preincubated (30 min at 37degreesC) in HBSS containing either 3 microg/ml non-specific mouse immunoglobulin (IgG; Dako) or a mouse blocking monoclonal antibody specific to integrin beta1 (HUTS-4; 1:1000; Chemicon), alpha4 (P4G9; 1:1000; Chemicon), alpha5 (SAM-1; 1:100; Chemicon), alphanubeta3 (LM609; 1:100; Chemicon), or alphanubeta5 (P1F6; 1:1000; Chemicon). A total of 6x104 cells in 500 microl EGM2 supplemented with 0.2% BSA were seeded to the precoated wells and allowed to adhere for 30 min at 37degreesC. Adherent cells were quantified by counting in six randomly selected fields per well (magnification 200x; Axiovert 200; Carl Zeiss MicroImaging).
###end p 25
###begin title 26
Transwell migration assay
###end title 26
###begin p 27
###xml 296 297 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 331 332 310 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 364 365 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 397 399 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#957;</sub>
###xml 403 404 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 439 441 402 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#957;</sub>
###xml 445 446 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 493 494 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
###xml 245 250 <span type="species:ncbi:10090">mouse</span>
Cell migration assay were performed by 8-microm-pore transwells (Costar). The VEGF-A induced differentiated hPMSCs were preincubated (30 min at 37degreesC) in HBSS containing either 3 microg/ml non-specific mouse IgG (Dako) or function-blocking mouse monoclonal antibody specific to integrin beta1 (HUTS-4; 1:1000; Chemicon), alpha4 (P4G9; 1:1000; Chemicon), alpha5 (SAM-1; 1:100; Chemicon), alphanubeta3 (LM609; 1:100; Chemicon), or alphanubeta5 (P1F6; 1:1000; Chemicon). A total of 5 to 8x105 hPMSCs were added to the upper chamber of the transwell and allowed to migrate for 20 hours at 37degreesC with EGM2 (600 microl; Promocell) in the presence or absence of VEGF-A (50 ng/ml) together with either 0.5 to 50 microg/ml of fibronectin (Upstate) or vitronectin (Upstate) in the lower chamber. The number of cells transmigrated to the lower compartment was quantified by counting migrated cells in six randomly selected fields per well (magnification 200x; Axiovert 200; Carl Zeiss MicroImaging).
###end p 27
###begin title 28
In vitro angiogenesis
###end title 28
###begin p 29
###xml 352 353 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 387 388 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 420 421 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 453 455 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#957;</sub>
###xml 459 460 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 495 497 462 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#957;</sub>
###xml 501 502 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 597 598 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 741 743 700 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 1149 1153 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Yang2">[39]</xref>
###xml 1155 1162 1108 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 269 274 <span type="species:ncbi:10090">mouse</span>
Induction of capillary tube formation was performed using an In Vitro Angiogenesis kit (Chemicon) as recommended by the manufacturer. VEGF-A-induced differentiated hPMSCs cells were preincubated (30 min at 37degreesC) in HBSS containing either 3 microg/ml non-specific mouse IgG (Dako) or function-blocking monoclonal antibody specific to integrin beta1 (HUTS-4; 1:1000; Chemicon), alpha4 (P4G9; 1:1000; Chemicon), alpha5 (SAM-1; 1:100; Chemicon), alphanubeta3 (LM609; 1:100; Chemicon), or alphanubeta5 (P1F6; 1:1000; Chemicon). After blocking with these antibodies, cells were resuspended to 1x105 cells/ml in EGM2, after which 100 microl/well of cell suspension was added onto a gel of polymerized basement membrane-like material (ECMatrixTM). The cells were incubated for 6 hours at 37degreesC for full development of capillary-like network structures. Tube formation was quantified by counting the number of polygonal tubes as well as cumulative tube length (long axis). In instances where several tube-like structures merged together or branched, the total length of the tubes was calculated as the sum of the length of the individual branches [39]. Results are represented as total tube length (microm) or number for six random photographic fields per experimental condition (magnification 50x; Axiovert 200; Carl Zeiss MicroImaging). The experiment was independently repeated three times.
###end p 29
###begin title 30
###xml 24 29 <span type="species:ncbi:9031">chick</span>
In vivo angiogenesis by chick chorioallantoic membrane assay
###end title 30
###begin p 31
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Kim2">[40]</xref>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 357 358 357 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 410 411 407 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 445 446 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 478 479 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1531 1533 1510 1512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 4 9 <span type="species:ncbi:9031">chick</span>
###xml 179 186 <span type="species:ncbi:9031">chicken</span>
###xml 521 526 <span type="species:ncbi:10090">mouse</span>
###xml 1663 1668 <span type="species:ncbi:9606">human</span>
The chick chorioallantoic membrane (CAM) assay was modified from a prior report [40]. CAM was exposed by cutting a window (2 cm2) on one side of 10-day-old specific pathogen free chicken eggs. A 3-mm-thick sterile straw disk, 8 mm in diameter, was placed on the CAM for 3-dimensional culture on an area with a minimum of small blood vessels. A total of 1x105 of hPMSCs pretreated either with anti-integrin beta1 (HUTS-4; 1:1000; Chemicon), alpha4 (P4G9; 1:1000; Chemicon), alpha5 (SAM-1; 1:100; Chemicon) or non-specific mouse IgG (1:50; Dako) and resuspensed in 100 microl EGM2 were placed into the straw. The window in the shell was sealed with adhesive tape and the egg was incubated for 48 hours. Representative CAMs from each treatment group were photographed under a dissecting microscope (10x) and counted. The number of fine blood vessel branch points in the region of the sample was counted. As angiogenesis is characterized by the sprouting of new vessels in response to hPMSCs, counting blood vessel branching points is a useful quantitative means of obtaining an angiogenic index. At least 6 embryos were used per treatment group. Data were evaluated in terms of average number of blood vessel branching points per treatment group +/- SD. CAMs were further excised, cryopreserved, cut into 5-microm sections, and immunostained with vWF, CD31 and CD105 as described above. For cell tracking, hPMSCs with or without induction into endothelial differentiation by VEGF-A were labeled with green fluorescence dye CellTrackerTM CMFDA (5 microM, Molecular Probes, Invitrogen) before implanting into CAM. The CAM was immunostained by primary antibody against human vWF (1:800, Sigma-Aldrich) after cell transplantation. Quantification of new vessel formation that contained hPMSC incorporation or the number of hPMSCs that incorporated into the endothelia of each vessel were conducted in 10 fields (400x) for each section from 3 randomly selected sections of each CAM tissue.
###end p 31
###begin title 32
Statistical analysis
###end title 32
###begin p 33
###xml 174 175 174 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 381 382 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The measurements of counting were conducted blind by two independent observers. The intra-class correlation coefficient for intra- and inter-rater reliability of cell counts >0.75 was considered good agreement. The data are described as means +/- SD. Differences were assessed using the independent-samples t test, paired-samples t test, or Mann Whitney U test when appropriate. A P value of less than 0.05 was considered significant. The statistical software used is SSPS version 12.0 (Chicago,IL,USA).
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human placenta-derived multipotent mesenchymal stromal cells
###end title 35
###begin p 36
###xml 263 270 263 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g001">Fig. 1A</xref>
###xml 415 422 415 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g001">Fig. 1A</xref>
###xml 689 696 685 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g001">Fig. 1A</xref>
###xml 888 889 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 896 897 884 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 904 905 888 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 911 912 892 893 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 918 919 896 897 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 929 930 904 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 942 943 914 915 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 952 953 921 922 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 973 980 942 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g001">Fig. 1C</xref>
Flow cytometric analysis showed that hPMSCs were positive for the multipotent mesenchymal stromal cell markers CD13, CD29, CD44, CD54, CD73, CD90, CD105, and CD166, but negative for the hematopoietic stem cell markers CD45 and CD34 and the monocytic marker CD14 (Fig. 1A). These characteristics are consistent with multipotent mesenchymal stromal cells. The cells expressed HLA-ABC (MHC I), but not HLA-DR (MHC II; Fig. 1A). hPMSCs were also positive for the embryonic stem cell-associated cell surface marker stage-specific embryonic antigen (SSEA)-4 (38.2+/-10.4%), and the pluripotent stem cell-specific transcription factor Oct-4 (78.4+/-11.5%). However, hPMSCs do not express SSEA-1 (Fig. 1A), TRA-1-60, or TRA-1-81 (not shown). The absence of CD34 in the hPMSC isolate excludes endothelial cell contamination. Flow cytometry analysis further showed hPMSCs to express integrins alphav, alpha4, alpha5, beta1, beta3, and beta5, while beta2 and beta4 were undetectable (Fig. 1C).
###end p 36
###begin title 37
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human placental multipotent mesenchymal stromal cells (hPMSCs).
###end title 37
###begin p 38
###xml 517 522 <span type="species:ncbi:9606">human</span>
(A) Flow cytometry analysis of cell-marker expression by hPMSCs. The cells express CD13, CD29, CD44, CD54, CD73, CD90, CD105, CD166, HLA-ABC, Oct-4, and SSEA-4, but are negative for HLA-DR, CD34, CD45, and SSEA-1. The shaded area shows the profile of the cells stained by a control antibody of matching isotype. Ten thousand cells were counted from each sample. (B) Analysis of stem cell markers on hPMSCs by RT-PCR analysis. Three different strains of hPMSCs are shown in lane 1 to 3. Lane 4 was RNA obtained from a human embryonic stem cell line (hES 6; ES Cell International, USA) and served as a positive control. PCR was performed for 35 cycles to demonstrate Oct-4 and Sox-2 transcripts, and 30 cycles for Nanog. (C) The expression of integrin subunits on hPMSCs determined by flow cytometry. The data shown are representative of 3 different experiments. (D) Osteogenic differentiation of hPMCs resulted in positive staining for Alizarin Red S, indicating the presence of calcium salt deposition associated with the matrix. (E) Adipocyte differentiation resulted in cytoplasmic lipid droplets that were Oil Red O-positive. (F) Undifferentiated hPMSCs used as a control for Oil Red O staining. The cells were counterstained with Mayer's hematoxylin (E, F). Scale bar: 100 microm.
###end p 38
###begin p 39
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Niwa1">[41]</xref>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Richards1">[43]</xref>
###xml 157 164 157 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g001">Fig. 1B</xref>
###xml 412 419 412 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g001">Fig. 1D</xref>
###xml 544 551 544 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g001">Fig. 1E</xref>
###xml 590 597 590 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g001">Fig. 1F</xref>
RT-PCR analysis of total RNA from cultured hPMSCs showed expression of Oct-4, Nanog and Sox-2, transcription factors associated with pluripotency [41]-[43] (Fig. 1B). hPMSC multipotency was demonstrated using standard osteocyte and adipocyte differentiation assays. In the former case hPMSCs formed nodules and stained with Alizarin Red S, indicating calcium salt crystallization and osteogenic differentiation (Fig. 1D). In the latter assay, hPMSCs developed Oil Red O-positive cytoplasmic lipid droplets indicating adipocyte differentiation (Fig. 1E). This was not seen in control cells (Fig. 1F).
###end p 39
###begin title 40
Differentiation of hPMSCs into endothelial cells
###end title 40
###begin p 41
###xml 243 249 243 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2</xref>
###xml 365 372 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2A</xref>
###xml 457 464 457 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2B</xref>
###xml 473 480 473 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2C</xref>
###xml 496 503 496 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2D</xref>
###xml 532 541 532 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2E&#8211;H</xref>
###xml 779 786 779 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2H</xref>
###xml 835 842 835 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2J</xref>
###xml 911 918 911 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2I</xref>
###xml 1385 1392 1357 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2K</xref>
hPMSCs were cultured in the presence of EGM2 with 2% FBS and 50 ng/ml VEGF-A for 14 to 21 days, then stained with antibodies to the endothelial markers: CD31, CD34, VE-cadherin, VEGFR-1, VEGFR-2, vWF, and CD105, and assayed by flow cytometry (Fig. 2). Undifferentiated hPMSCs cultured with regular medium showed no significant immunofluorescence staining for CD31 (Fig. 2A), CD34, VE-cadherin or vWF (not shown). The overall fluorescence intensity of CD31 (Fig. 2B), CD34 (Fig. 2C), VE-cadherin (Fig. 2D), VEGFR-1, VEGFR-2 and vWF (Fig. 2E-H) in differentiated hPMSCs was markedly enhanced after 21 days of cultivation, indicating the differentiation of hPMSC to endothelial cells. Weibel-Palade bodies were clearly visible within differentiated hPMSCs under high magnification (Fig. 2H). CD105 was expressed in differentiated hPMSCs (Fig. 2J). However, the undifferentiated cells were also positive for CD105 (Fig. 2I). Flow cytometry revealed a substantial increase of expression of CD31 (3.1+/-1.6% vs. 56.6+/-11.4%; P = 0.012), CD34 (1.2+/-1.0% vs. 46.3+/-14.1%; P = 0.029), VE-cadherin (0.8+/-0.7% vs. 14.1+/-4.4%; P = 0.038), VEGFR-1 (1.5+/-1.1% vs. 27.0+/-6.2%; P = 0.015), VEGFR-2 (1.9+/-1.0% vs. 46.4+/-2.7%; P = 0.001) and vWF (0.8+/-0.7% vs. 63.2+/-7.1%; P = 0.004), but not CD105 (94.6+/-6.3% vs. 88.1+/-8.3%; P = 0.825) in differentiated hPMSCs compared to control cells (Fig. 2K).
###end p 41
###begin title 42
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human placental multipotent mesenchymal stromal cells (hPMSCs) after inducing differentiation into endothelial cells.
###end title 42
###begin p 43
###xml 944 949 <span type="species:ncbi:9606">human</span>
Immunofluorescence staining of CD31 in undifferentiated hPMSCs is shown in (A) as a negative control. Immunofluorescence of endothelial markers in differentiated hPMSCs under induced culture conditions: (B) CD31, (C) CD34, (D) VE-cadherin, (E) VEGFR-1, (F) VEGFR-2, (G) von Willebrand factor, (H) von Willebrand factor under high magnification (Scale bar: 1 microm); Weibel-Palade bodies were visible within the differentiated hPMSC cytoplasm (arrow). CD105 was positive in (I) undifferentiated hPMSCs and (J) hPMSCs differentiated into endothelial cells. Cell nuclei were counterstained with DAPI. Scale bar: 10 microm. (K) Flow cytometry analysis of endothelial cell markers on the hPMSC surface before and after differentiation induced by VEGF-A. (L) mRNA for endothelial cell markers was amplified from 2 different strains of undifferentiated hPMSCs (lane 1 and 2) and hPMSCs differentiated into endothelial cells (lane 3 and 4). mRNA from human umbilical vein endothelial cells was used as a positive control (lane 5). The data shown are representative of 3 different experiments.
###end p 43
###begin p 44
###xml 202 205 202 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Fukuchi1">[5]</xref>
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g002">Fig. 2L</xref>
Endothelial differentiation of hPMSCs was further revealed by mRNA analysis. Two different strains of hPMSCs were used for comparison before and after differentiation. Consistent with a previous report [5], the hPMSCs express various hematopoietic genes. Transcription from the CD34 and CD105 genes was variable between hPMSC isolates. However, after differentiation, the cells showed increased levels of mRNA encoding CD31, VE-cadherin, VEGFR-1, VEGFR-2, and vWF (Fig. 2L).
###end p 44
###begin p 45
###xml 56 57 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 64 65 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 71 72 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 79 80 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 84 85 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 96 97 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 101 102 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 145 146 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 148 159 119 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g003">Fig. 3E, 3F</xref>
###xml 169 170 137 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 172 183 140 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g003">Fig. 3A, 3B</xref>
###xml 271 272 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 274 285 238 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g003">Fig. 3C, 3D</xref>
###xml 293 294 253 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 298 299 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 301 312 258 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g003">Fig. 3G, 3H</xref>
###xml 323 324 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 328 329 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 331 342 281 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g003">Fig. 3I, 3J</xref>
###xml 382 383 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 390 391 332 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 398 399 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 405 406 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 412 413 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 423 424 352 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 669 670 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 679 680 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 707 718 629 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g003">Fig. 3K, 3L</xref>
###xml 788 789 706 707 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 793 794 708 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1056 1060 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Kim1">[21]</xref>
###xml 1062 1066 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Eliceiri1">[44]</xref>
###xml 1068 1072 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Hynes1">[45]</xref>
Immunofluorescence staining demonstrated integrins alpha4, alpha5, beta1, alphavbeta3, and alphavbeta5 in undifferentiated hPMSCs. Integrin alpha5 (Fig. 3E, 3F) and beta1 (Fig. 3A, 3B) were significantly increased after endothelial differentiation, but not integrin alpha4 (Fig. 3C, 3D), alphavbeta3 (Fig. 3G, 3H), or alphavbeta5 (Fig. 3I, 3J). Cell surface levels of integrin alphav, alpha4, alpha5, beta1, beta3, and beta5 subunits were assayed by flow cytometry before and after endothelial differentiation. Mean specific fluorescence (which corresponds to the increase in fluorescence intensity relative to second antibody alone) was higher for both integrins alpha5 and beta1 in differentiated hPMSCs (Fig. 3K, 3L). This suggests a significant increase in cell surface integrin alpha5beta1 expression as the cells differentiated. In contrast, no increase was observed in expression of the alphavbeta3 or alphavbeta5 integrin, which have also been implicated in binding of fibronectin, vitronectin and other RGD-containing ligands, and in angiogenesis [21], [44], [45].
###end p 45
###begin title 46
###xml 38 43 <span type="species:ncbi:9606">human</span>
Integrin expression at the surface of human placental multipotent mesenchymal stromal cells (hPMSCs) before and after inducing differentiation into endothelial cells.
###end title 46
###begin p 47
###xml 150 151 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 165 166 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 180 181 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 195 196 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 200 201 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 218 219 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 223 224 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 324 325 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 334 335 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 852 853 810 811 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 862 863 817 818 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Undifferentiated hPMSCs: A, C, E, G, I; differentiated hPMSCs: B, D, F, H, J. The cells were immunostained using antibody against integrin (A, B) beta1, (C, D) alpha4, (E, F) alpha5, (G, H) alphavbeta3, or (I, J) alphavbeta5. Scale bar: 10 microm. Immunofluorescence staining revealed significant increases in integrin alpha5 and beta1. (K) The change of hPMSC surface integrin expression after differentiation induced by VEGF-A was measured by flow cytometry and expressed in fluorescence intensity units. Change in fluorescence intensity is an index of integrin surface concentration per cell. (L) Quantification of specific mean fluorescence intensity (which corresponds to the increase in fluorescence intensity relative to second antibody alone) is shown (+/-SD, n = 3). The specific mean fluorescence intensity was higher for both integrins alpha5 and beta1 in differentiated hPMSCs. C: controls; E: endothelial cell differentiation induced by VEGF-A.
###end p 47
###begin title 48
###xml 30 31 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 35 36 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Fibronectin and integrin alpha5beta1 promote VEGF-A-induced differentiated hPMSC adhesion and migration
###end title 48
###begin p 49
###xml 20 21 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 25 26 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 293 294 282 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 298 299 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 309 310 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 314 315 293 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 582 589 561 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g004">Fig. 4A</xref>
###xml 748 749 723 724 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 758 759 730 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 849 850 817 818 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 854 855 819 820 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 865 866 826 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 870 872 828 830 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5.</sub>
###xml 959 966 917 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g004">Fig. 4B</xref>
###xml 1016 1017 970 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1021 1022 972 973 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1160 1161 1107 1108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1165 1166 1109 1110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Since integrin alpha5beta1 is a specific receptor for fibronectin, and angiogenesis often involves endothelial cell adhesion and migration within a fibronectin-rich ECM, we investigated the ability of differentiated cells to interact with fibronectin. As the cells also express integrins alphavbeta3 and alphavbeta5, vitronectin was used as a control ligand. Differentiated hPMSCs adhered to fibronectin more efficiently than to vitronectin (P<0.001). VEGF-A significantly increased the adhesion of differentiated hPMSCs to fibronectin but not to vitronectin- or BSA-coated plates (Fig. 4A). Significant inhibition of differentiated hPMSC attachment to fibronectin-coated plates was observed in the presence of blocking antibodies to integrin alpha5 and beta1, whereas very limited inhibition effect was observed in the presence of antibody to alphavbeta3 and alphavbeta5. Attachment to vitronectin was low, and blocking antibodies had no significant effect (Fig. 4B). These experiments indicated that integrin alpha5beta1 on the surface of differentiated hPMSCs is important for mediating cell attachment to fibronectin, with a further contribution from alphavbeta3.
###end p 49
###begin title 50
###xml 50 55 <span type="species:ncbi:9606">human</span>
Adhesion and migration assays were performed with human placental multipotent mesenchymal stromal cells (hPMSCs) and various integrin-blocking antibodies.
###end title 50
###begin p 51
###xml 712 713 708 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 719 720 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 729 730 718 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 734 735 720 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 759 760 741 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 764 765 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1312 1313 1275 1276 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1322 1323 1282 1283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
(A). hPMSCs were induced to differentiate into endothelial cells, then plated onto surfaces coated with BSA (NC), fibronectin, or vitronectin in the presence or absence of VEGF-A. The differentiated hPMSCs adhered to fibronectin more efficiently than to vitronectin (P<0.001). VEGF-A significantly increased the adhesion of differentiated hPMSCs to fibronectin but not to vitronectin or plates coated with 2.5% BSA solution (NC). (B) Inhibition of differentiated hPMSC adhesion to fibronectin and vitronectin in the presence of blocking antibodies to integrin subunits. A significant inhibition of differentiated hPMSC adhesion to fibronectin was observed in the presence of blocking antibodies to integrin alpha5, beta1 or alphavbeta3, but not integrin alphavbeta5. The number of differentiated hPMSCs attached to vitronectin was low. (C) Transwell migration of differentiated hPMSCs induced by VEGF-A (50 ng/ml) with or without fibronectin (0.5 to 50 microg/ml) or vitronectin (0.5 to 50 microg/ml). Fibronectin in the presence of VEGF-A stimulated migration. (D) Inhibition of differentiated hPMSC transwell migration induced by VEGF-A (50 ng/ml) with or without fibronectin (50 microg/ml). Various blocking antibodies to integrin subunits and non-specific IgG were used. Antibodies to integrin subunits alpha5 and beta1 were inhibitory. Error bar: SD; Ab: antibody; ECM: extracellular matrix.
###end p 51
###begin p 52
###xml 187 194 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g004">Fig. 4C</xref>
###xml 302 309 298 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g004">Fig. 4C</xref>
###xml 359 360 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 368 369 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 464 465 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 472 473 453 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 477 478 455 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 488 489 462 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 493 494 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 510 517 481 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g004">Fig. 4D</xref>
###xml 685 686 652 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 690 691 654 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Migration of differentiated hPMSC was enhanced by either VEGF-A (50 ng/ml) or fibronectin (50 microg/ml) alone, but the combination of VEGF-A and fibronectin produced an additive effect (Fig. 4C). In contrast, neither vitronectin alone nor the combination of VEGF-A and vitronectin promoted migration (Fig. 4C). In the presence of antibodies to integrin alpha5 or beta1, cell migration to VEGF-A and fibronectin together was suppressed, whereas antibodies to alpha4, alphavbeta3, or alphavbeta5 had no effect (Fig. 4D). These results suggest strongly that enhanced adhesion and migration of differentiated hPMSC in the presence of VEGF-A and fibronectin are dependent on integrin alpha5beta1.
###end p 52
###begin title 53
###xml 100 101 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 105 106 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
The ability of differentiated hPMSCs to form capillary-like structures is mediated by integrin alpha5beta1
###end title 53
###begin p 54
###xml 234 241 234 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5A</xref>
###xml 272 279 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5B</xref>
###xml 458 465 458 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5B</xref>
###xml 661 668 661 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5C</xref>
###xml 769 770 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 772 779 769 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5D</xref>
###xml 789 790 782 783 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 792 799 785 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5F</xref>
###xml 839 840 828 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 847 848 832 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 852 853 834 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 863 864 841 842 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 868 869 843 844 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 904 919 879 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5E, 5G, 5H</xref>
###xml 935 942 910 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5M</xref>
###xml 1070 1077 1045 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5J</xref>
###xml 1086 1093 1061 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5K</xref>
###xml 1107 1114 1082 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Fig. 5L</xref>
###xml 1117 1126 1092 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g005">Figure 5I</xref>
###xml 132 137 <span type="species:ncbi:9606">human</span>
To study the molecular mechanisms underlying capillary-like morphogenesis in differentiated hPMSCs, either differentiated hPMSCs or human umbilical vein endothelial cells (HUVECs) were seeded onto a basement membrane-like gel. HUVEC (Fig. 5A) and undifferentiated hPMSCs (Fig. 5B) were used as positive and negative controls, respectively. The undifferentiated hPMSCs showed very few capillary-like structures after 6 hours, and most cells remained rounded (Fig. 5B). The differentiated hPMSCs typically showed cytoplasmic projections, spikes and extensions, and had elongated within 6 hours, with most cells becoming integrated into capillary-like structures (Fig. 5C). Formation of these structures was strongly inhibited in the presence of antbodies to integrin beta1 (Fig. 5D) or alpha5 (Fig. 5F). Blocking antibodies to integrin alpha4, alphavbeta3, or alphavbeta5 did not show inhibitory activity (Fig. 5E, 5G, 5H; quantified in Fig. 5M). Immunostaining confirmed that cells in the capillary-like structures express the specific endothelial markers including vWF (Fig. 5J), CD31 (Fig. 5K), and CD105 (Fig. 5L). Figure 5I was the cells stained by non-specific IgG as a control.
###end p 54
###begin title 55
###xml 80 85 <span type="species:ncbi:9606">human</span>
In vitro angiogenesis: formation of capillary-like structures by differentiated human placental multipotent mesenchymal stromal cells (hPMSCs).
###end title 55
###begin p 56
###xml 61 63 61 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 472 473 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 484 485 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 496 497 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 508 509 493 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 513 514 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 528 529 506 507 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 533 534 508 509 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 743 744 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 753 754 717 718 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 808 809 768 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 816 817 772 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 821 822 774 775 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 832 833 781 782 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 837 838 783 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 940 942 886 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 1204 1206 1146 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 1485 1486 1424 1425 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1495 1496 1430 1431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 69 74 <span type="species:ncbi:9606">Human</span>
hPMSCs were trypsinized, seeded on wells coated with ECMatrixTM. (A) Human umbilical vein endothelial cells and (B) undifferentiated hPMSCs were used as positive and negative control (shown after 6 hours of culture). (C) hPMSCs induced to differentiate into endothelial cells form characteristic capillary-like structures. Cell elongation and cell interconnecting cell networks were observed. Differentiated hPMSCs were pretreated with antibodies against (D) integrin beta1, (E) alpha4, (F) alpha5, (G) alphavbeta3, or (H) alphavbeta5. Scale bar: 200 microm. Representative photomicrographs of 3 different experiments are shown. This ability of differentiated hPMSCs to form capillary-like structures was strongly diminished when integrin beta1 or alpha5 was inhibited. Blocking antibodies to integrins alpha4, alphavbeta3, or alphavbeta5 did not inhibit the formation of capillary-like structures. The capillary-like structures on ECmatrixTM gel were immunostained using antibody against (I) non-specific IgG or specific endothelial markers (J) von Willebrand factor, (K) CD31, and (L) CD105. Scale bar: 50 microm. Arrows indicate von Willebrand factor, CD31 and CD105 positive cells present in ECmatrixTM gel. (M) Quantification of the capillary-like structures by measuring the polygonal network (upper panel) and the cumulative tube length (lower panel) formed by differentiated hPMSCs. A significant inhibition of capillary-like structure formation was observed when integrin beta1 or alpha5 antibody was applied to the cells. Error bar: SD.
###end p 56
###begin title 57
###xml 14 15 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 19 20 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Integrin alpha5beta1 mediates the angiogenesis of differentiated hPMSCs in vivo
###end title 57
###begin p 58
###xml 133 142 133 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6A&#8211;G</xref>
###xml 181 188 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6H</xref>
###xml 307 318 307 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6B, 6H</xref>
###xml 504 520 504 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6A&#8211;C and 6H</xref>
###xml 643 644 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 652 653 645 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 684 698 677 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6D and 6F</xref>
###xml 732 733 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 819 833 808 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6E and 6G</xref>
###xml 952 961 941 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6J&#8211;L</xref>
###xml 1020 1027 1009 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6I</xref>
###xml 1195 1196 1180 1181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1205 1206 1187 1188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 82 87 <span type="species:ncbi:9031">chick</span>
###xml 750 755 <span type="species:ncbi:10090">mouse</span>
###xml 925 930 <span type="species:ncbi:9606">human</span>
Differentiated or undifferentiated hPMSCs were implanted onto CAMs of ten-day-old chick eggs, and two days later the CAM was imaged (Fig. 6A-G) and vessel branching points counted (Fig. 6H). In contrast to the short-term incubation in vitro, the transplanted undifferentiated hPMSCs augmented angiogenesis (Fig. 6B, 6H). However, there was a statistically significant increase of neovascularization in the CAM transplanted by differentiated hPMSCs compared to that of undifferentiated hPMSCs or control (Fig. 6A-C and 6H). The angiogenic activity of the differentiated hPMSCs was significantly reduced by preincubation with anti-integrin alpha5 or beta1 prior to transfer to the CAM (Fig. 6D and 6F). Addition of anti-integrin alpha4 or non-specific mouse IgG antibody had no significant effect on angiogenic activity (Fig. 6E and 6G). Immunostaining of the CAM further revealed cells within the neovessels were positive for human vWF, CD31 and CD105 (Fig. 6J-L). The CAM without hPMSC transplantation was vWF negative (Fig. 6I). These results demonstrated that the differentiated hPMSCs contributed to the neovascularization of CAM and the angiogenic activity is mediated through integrin alpha5 and beta1.
###end p 58
###begin title 59
###xml 31 36 <span type="species:ncbi:9031">chick</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
Stimulation of angiogenesis in chick chorioallantoic membrane (CAM) by undifferentiated or differentiated human placental multipotent mesenchymal stromal cells (hPMSCs).
###end title 59
###begin p 60
###xml 558 559 555 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 570 571 563 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 582 583 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 907 908 892 893 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 916 917 898 899 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1517 1519 1499 1501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 674 681 <span type="species:ncbi:9031">chicken</span>
###xml 1129 1134 <span type="species:ncbi:9606">human</span>
###xml 1458 1463 <span type="species:ncbi:9606">human</span>
###xml 1915 1920 <span type="species:ncbi:9606">human</span>
Small tortuous blood vessels, typical of neovascularization, were visible in the CAM. The development of new blood vessels was determined by counting branch points (arrows) after 48 hours of cell transplantation. Sprouting and branching vessels (arrows) are prominent in the CAM transplanted by (C) differentiated hPMSCs compared to the (A) negative control (fresh culture medium) without hPMSC transplantation and (B) undifferentiated hPMSCs transplantation. CAMs were implanted by differentiated hPMSCs pre-treated with antibodies against integrin (D) beta1, (E) alpha4, (F) alpha5, or (G) non-specific IgG. Scale bar: 3 mm. Representative photomicrographs of 6 different chicken embryos are shown. (H) Quantification of new blood vessels formed by negative control (NC; fresh culture medium) or hPMSCs in CAM. The angiogenic effect was substantially reduced in hPMSCs pre-treated with anti-integrin alpha5 or beta1 antibody. Cryosections of CAMs were immunostained by (I) von Willebrand factor (vWF), (J) vWF, (K) CD31, and (L) CD105 antibodies. (I) CAM without hPMSC transplantation was negative for vWF staining, indicating human vWF antibody does not cross react with CAM. (J-L) Arrows indicated vWF, CD31 and CD105-positive cells present in CAM, revealing that differentiated hPMSCs contributed to neovascularization. CAM transplanted with (M) undifferentiated hPMSCs or (O) differentiated hPMSCs were immunostained using a rhodamine (red)-conjugated human vWF antibody. The hPMCs were labeled with CellTrackerTM CMFDA (green). DAPI (blue) staining was used to identify nuclei. The incorporation of hPMSC into CAM endothelium that expressed vWF would reveal yellow signal. Differentiated hPMSCs were widely incorporated into endothelium of CAM vessels (O). A large arrow indicates the hPMSCs incorporated into CAM vessel endothelium. A small arrow indicates a nearby vessel lacking both engrafted hPMSCs and human vWF expression (M). Plenty of nucleated red blood cells were observed within the lumens of vessels. (N, P) Hematoxylin-eosin stained serial sections with inset areas matching images of M and O. Scale bar: 50 microm. (Q) Quantification of the number of new vessels formation that contained hPMSCs after transplantation of differentiated or undifferentiated hPMSCs. (R) Quantification of the number of hPMSCs incorporated into vessel endothelium after transplantation of differentiated or undifferentiated hPMSCs. D hPMSCs: differentiated hPMSCs; U hPMSCs: undifferentiated hPMSCs; Error bar: SD.
###end p 60
###begin p 61
###xml 124 135 124 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6O, 6Q</xref>
###xml 230 232 230 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 288 299 288 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6M, 6O</xref>
###xml 494 501 490 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6Q</xref>
###xml 645 652 637 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006913-g006">Fig. 6R</xref>
To assess hPMSC distribution after transplantation, differentiated hPMSCs were found distributed widely in CAM vasculature (Fig. 6O, 6Q). Immunofluorescence demonstrated a part of these incorporated hPMSCs labeled with CellTrackerTM CMFDA expressed endothelial cell-specific protein vWF (Fig. 6M, 6O). A significantly higher number of vessels of CAM contained hPMSCs after transplantation with differentiated hPMSCs compared to undifferentiated cells (79.4+/-11.7% vs. 45.5+/-16.5%; P = 0.001; Fig. 6Q), and differentiated hPMSCs were significantly more numerous in the vessels than undifferentiated cells (81.1+/-8.2% vs. 38.7+/-9.2%; P<0.001; Fig. 6R).
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 543 544 540 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 554 555 547 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 579 580 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 587 588 572 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 594 595 576 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 604 605 583 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
hPMSCs have the potential to differentiate into endothelial cells under appropriate conditions both in vitro and in vivo. The differentiated cells express a panel of endothelial cell makers including vWF, CD31, CD34, VE-cadherin and the endothelial cell receptors VEGFR-1 and VEGFR-2 in vitro and in vivo. They can form capillary tube-like structures in vitro and have a greater capacity to augment angiogenesis in the CAM assay than undifferentiated cells. The ability of differentiated hPMSCs to form new blood vessels involves integrin beta1 and alpha5, but not integrin alphav, alpha4, beta3, or beta5.
###end p 63
###begin p 64
###xml 35 38 35 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Fukuchi1">[5]</xref>
###xml 39 42 39 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-PortmannLanz1">[8]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Pittenger1">[31]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Orlic1">[46]</xref>
###xml 245 248 245 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Fukuchi1">[5]</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Barry1">[47]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Barry2">[48]</xref>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Niwa1">[41]</xref>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Richards1">[43]</xref>
###xml 778 781 778 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Yen1">[6]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Gang2">[49]</xref>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Battula1">[50]</xref>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 618 623 <span type="species:ncbi:9606">human</span>
In agreement with previous reports [5]-[8], the phenotype of hPMSC is similar to that of human bone marrow-derived multipotent mesenchymal stromal cells [31], [46]. Although undifferentiated hPMSCs express various hematopoietic gene transcripts [5], they do not bear the hematopoietic marker CD45. They express adhesion molecules and mesenchymal stem cell markers, including CD29, CD44, CD73, CD105, and CD166 [47], [48]. We also observed that hPMSCs express genes that are considered to be specific to pluripotent embryonic cells [41]-[43] such as Oct-4 and SSEA-4. SSEA-4 was previously thought to mark specifically human embryonic stem cells, but has also been observed in subpopulations of adult bone marrow-derived or placenta-derived multipotent mesenchymal stromal cells [6], [49], [50].
###end p 64
###begin p 65
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Ferrara1">[51]</xref>
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Dvorak1">[52]</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Yoder1">[53]</xref>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-vanderLoo1">[12]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Hurley1">[54]</xref>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Dao1">[55]</xref>
###xml 303 304 299 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 308 309 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 316 317 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 321 322 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 332 333 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 337 338 316 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 338 342 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Kim1">[21]</xref>
###xml 344 348 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Eliceiri1">[44]</xref>
###xml 350 354 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Elices1">[56]</xref>
###xml 355 359 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Stupack1">[58]</xref>
###xml 461 462 437 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 472 473 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 661 662 629 630 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 666 667 631 632 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 917 918 878 879 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 922 923 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Fibronectin and VEGF-A are important regulators of blood vessel growth [51], [52]. Fibronectin is highly expressed within the hematopoietic microenvironment [53] and is involved in the adhesion of hematopoietic stem and progenitor cells [12], [54], [55]. Fibronectin acts as a ligand for integrins alpha5beta1, alpha4beta1 and alphavbeta3[21], [44], [56]-[58]. However, hPMSC adhesion to, and migration on fibronectin are specifically dependent on subunits beta1 and alpha5, the expression of both subunits increases upon endothelial differentiation, and angiogenesis is inhibited by blocking either of these two subunits. Hence we suggest the heterodimer alpha5beta1 interacts with fibronectin in the pericellular matrix to mediate key steps in angiogenesis. VEGF-A and fibronectin together significantly promote the adhesion and migration of hPMSCs. This augmentation effect is specific to fibronectin and the alpha5beta1 integrin.
###end p 65
###begin p 66
###xml 202 203 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 207 208 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 229 233 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Senger1">[59]</xref>
###xml 316 317 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 317 321 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Kale1">[60]</xref>
###xml 359 360 341 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 472 476 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Umeda1">[61]</xref>
###xml 646 647 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 651 652 626 627 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 661 662 632 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 666 667 634 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 831 835 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Milner1">[62]</xref>
###xml 836 840 804 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Dye1">[65]</xref>
###xml 874 875 838 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 879 880 840 841 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 889 890 846 847 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 894 895 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 984 988 938 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Umeda1">[61]</xref>
###xml 990 994 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Brooks1">[66]</xref>
###xml 1062 1063 1012 1013 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1067 1068 1014 1015 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1083 1084 1026 1027 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1088 1089 1028 1029 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1098 1099 1034 1035 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1103 1104 1036 1037 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 124 129 <span type="species:ncbi:9606">human</span>
Alterations of integrin expression may contribute to angiogenesis. It has been found that VEGF-A increases the migration of human dermal microvascular endothelial cells through the upregulation of alphavbeta3 integrin expression [59]. Cells undergoing a TGF-beta-induced angiogenic program up-regulate integrin alpha5[60]. A significant up-regulation of alpha5 subunit expression in vascular cells participating in choroidal neovascularization of injured eye was observed [61]. Furthermore, during the early phase of vessel sprouting, when interacting with fibronectin-rich interstitial ECM, activated endothelial cells may utilize integrin alpha5beta1 or alphavbeta3 to mediate the angiogenic response, later switching to other integrin subunits once basement membrane ligands such as laminin have assembled around the new vessel [62]-[65]. These reports suggest that alpha5beta1 or alphavbeta3 may play a role in neovascularization and provide a target for therapeutic intervention [61], [66]. We observed that VEGF-A increased the expression of integrin alpha5beta1, but not alphavbeta3 or alphavbeta5.
###end p 66
###begin p 67
###xml 87 88 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 92 93 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 93 97 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Francis1">[18]</xref>
###xml 125 129 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-George1">[16]</xref>
###xml 131 135 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-George2">[67]</xref>
###xml 184 185 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 189 190 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 190 194 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Francis1">[18]</xref>
###xml 222 223 204 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 340 344 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Yang1">[15]</xref>
###xml 422 426 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-George1">[16]</xref>
###xml 428 432 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-George2">[67]</xref>
###xml 451 452 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 580 584 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Taverna1">[17]</xref>
###xml 599 600 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 680 681 652 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 764 768 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Bloch1">[68]</xref>
###xml 864 865 832 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 879 883 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Bader1">[69]</xref>
###xml 902 903 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 926 927 888 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 936 937 895 896 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1029 1030 985 986 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1039 1040 992 993 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1088 1092 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Reynolds1">[70]</xref>
###xml 1116 1117 1066 1067 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1131 1132 1078 1079 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1274 1278 1221 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-HodivalaDilke1">[71]</xref>
###xml 1280 1284 1227 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Huang1">[72]</xref>
###xml 1400 1401 1343 1344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1407 1408 1347 1348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1417 1418 1354 1355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 234 239 <span type="species:ncbi:10090">mouse</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">Mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
Targeted gene ablation reveals that successful vasculogenesis depends on integrin alpha5beta1[18] and its ligand fibronectin [16], [67], and is not strongly dependent on integrin alphavbeta3[18]. Homozygotic integrin alpha5-deficient mouse embryos demonstrate vascularization disruption and die in utero with numerous morphological defects [15]. Fibronectin-deficient mice also develop defects in the yolk sac vasculature [16], [67]. In integrin alpha5-null embryonic cells, development of a complex vasculature is hindered with reduced cell proliferation and increased apoptosis [17]. Integrin beta1 is required for the initiation of basement membrane formation. In integrin beta1-null embryonic bodies, the complex vasculature formation is significantly delayed [68]. In contrast, vasculogenesis and angiogenesis in virtually all organs develop normally in alphav-null embryos [69]. Mice lacking beta3 integrins or both beta3 and beta5 integrins not only enhance tumor growth, but have enhanced angiogenesis. Thus, neither beta3 nor beta5 integrins are essential for neovascularization [70]. Furthermore, both beta3-null and beta5-null mice are viable, with unaffected developmental angiogenesis and adult angiogenesis such as retinal neovascularization and wound healing [71], [72]. These reports support our observations that angiogenesis by differentiated hPMSCs is independent of integrin alphav, beta3 and beta5.
###end p 67
###begin p 68
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Silva1">[73]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Liao1">[74]</xref>
###xml 1054 1058 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Kinnaird1">[75]</xref>
In contrast to the short incubation period of in vitro angiogenesis assays, both undifferentiated and differentiated hPMSCs were observed to enhance angiogenesis in the CAM assay. hPMSCs with positive vWF staining were observed to engraft in the endothelium of CAM. Direct integration of hPMSCs into CAM vasculature may augment sprouting angiogenesis. Similar to the study of ischemic brain or heart, multipotent mesenchymal stromal cells widely incorporated into vasculature and a subset of them was capable of differentiating into endothelial cells [73], [74]. However, hPMSCs after inducing endothelial cell differentiation have more cell numbers incorporated into CAM vessel and have a significantly greater angiogenic effect than that of undifferentiated hPMSC. Additionally, we cannot exclude other specific adhesion molecules or growth factors which may regulate distinct angiogenic responses. The paracrine factors expressed by hPMSCs may participate in enhancing angiogenesis other than the transdifferentiation into endothelial cells by hPMSCs [75].
###end p 68
###begin p 69
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006913-Nishishita1">[76]</xref>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
Our results are the first to identify a role for integrins in the regulation of angiogenesis initiated by hPMSCs. hPMSCs are a useful model to study the role of VEGF-A in differentiation and maturation of endothelial cells, and the role of integrins during placental angiogenesis and vasculogenesis. Transplantation of hPMSCs may offer potential for treating ischemic diseases. Transplantation of hPMSCs to the ischemic limbs of SCID mice significantly improved blood vessel formation and blood flow in the affected limbs [76]. In addition these cells could be utilized in the engineering of complex tissues in whcih vascularization is an essential feature.
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
Mesenchymal stem cells can be differentiated into endothelial cells in vitro.
###end article-title 71
###begin article-title 72
###xml 47 52 <span type="species:ncbi:9606">human</span>
Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord.
###end article-title 72
###begin article-title 73
###xml 34 39 <span type="species:ncbi:9606">human</span>
In vitro endothelial potential of human UC blood-derived mesenchymal stem cells.
###end article-title 73
###begin article-title 74
Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro.
###end article-title 74
###begin article-title 75
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human placenta-derived cells have mesenchymal stem/progenitor cell potential.
###end article-title 75
###begin article-title 76
###xml 36 41 <span type="species:ncbi:9606">human</span>
Isolation of multipotent cells from human term placenta.
###end article-title 76
###begin article-title 77
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells.
###end article-title 77
###begin article-title 78
Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration.
###end article-title 78
###begin article-title 79
###xml 74 79 <span type="species:ncbi:9606">human</span>
Synergism of biochemical and mechanical stimuli in the differentiation of human placenta-derived multipotent cells into endothelial cells.
###end article-title 79
###begin article-title 80
The role of vascular endothelial growth factor in blood vessel formation.
###end article-title 80
###begin article-title 81
Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions.
###end article-title 81
###begin article-title 82
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
###xml 32 37 <span type="species:ncbi:9606">human</span>
VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin.
###end article-title 82
###begin article-title 83
Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells.
###end article-title 83
###begin article-title 84
Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity.
###end article-title 84
###begin article-title 85
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Embryonic mesodermal defects in alpha 5 integrin-deficient mice.
###end article-title 85
###begin article-title 86
Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells.
###end article-title 86
###begin article-title 87
Reduced blood vessel formation and tumor growth in alpha5-integrin-negative teratocarcinomas and embryoid bodies.
###end article-title 87
###begin article-title 88
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies.
###end article-title 88
###begin article-title 89
Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin.
###end article-title 89
###begin article-title 90
Placental extracellular matrix: gene expression, deposition by placental fibroblasts and the effect of oxygen.
###end article-title 90
###begin article-title 91
Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin.
###end article-title 91
###begin article-title 92
The role of integrin alpha5beta1 in the regulation of corneal neovascularization.
###end article-title 92
###begin article-title 93
Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels.
###end article-title 93
###begin article-title 94
Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors.
###end article-title 94
###begin article-title 95
###xml 45 50 <span type="species:ncbi:9606">human</span>
Vasculogenesis and angiogenesis in the early human placenta.
###end article-title 95
###begin article-title 96
###xml 11 16 <span type="species:ncbi:9606">human</span>
Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy.
###end article-title 96
###begin article-title 97
Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms.
###end article-title 97
###begin article-title 98
###xml 11 16 <span type="species:ncbi:9606">human</span>
Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies.
###end article-title 98
###begin article-title 99
###xml 11 16 <span type="species:ncbi:9606">human</span>
Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation.
###end article-title 99
###begin article-title 100
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 105 109 <span type="species:ncbi:10116">rats</span>
Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats.
###end article-title 100
###begin article-title 101
###xml 32 37 <span type="species:ncbi:9606">human</span>
Multilineage potential of adult human mesenchymal stem cells.
###end article-title 101
###begin article-title 102
###xml 83 88 <span type="species:ncbi:9606">women</span>
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.
###end article-title 102
###begin article-title 103
###xml 63 68 <span type="species:ncbi:9606">human</span>
Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow).
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human endothelium: endovascular biopsy and molecular analysis.
###end article-title 104
###begin article-title 105
###xml 116 121 <span type="species:ncbi:9606">human</span>
Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer.
###end article-title 105
###begin article-title 106
###xml 105 113 <span type="species:ncbi:9606">patients</span>
Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes.
###end article-title 106
###begin article-title 107
###xml 84 89 <span type="species:ncbi:9606">human</span>
Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils.
###end article-title 107
###begin article-title 108
###xml 108 111 <span type="species:ncbi:10116">rat</span>
Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
###end article-title 108
###begin article-title 109
Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels.
###end article-title 109
###begin article-title 110
Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A.
###end article-title 110
###begin article-title 111
Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.
###end article-title 111
###begin article-title 112
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.
###end article-title 112
###begin article-title 113
###xml 29 34 <span type="species:ncbi:9606">human</span>
The transcriptome profile of human embryonic stem cells as defined by SAGE.
###end article-title 113
###begin article-title 114
Adhesion events in angiogenesis.
###end article-title 114
###begin article-title 115
Cell-matrix adhesion in vascular development.
###end article-title 115
###begin article-title 116
Bone marrow cells regenerate infarcted myocardium.
###end article-title 116
###begin article-title 117
###xml 70 75 <span type="species:ncbi:9606">human</span>
The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells.
###end article-title 117
###begin article-title 118
###xml 45 50 <span type="species:ncbi:9606">human</span>
The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105).
###end article-title 118
###begin article-title 119
SSEA-4 identifies mesenchymal stem cells from bone marrow.
###end article-title 119
###begin article-title 120
###xml 74 79 <span type="species:ncbi:9606">human</span>
Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody.
###end article-title 120
###begin article-title 121
The biology of VEGF and its receptors.
###end article-title 121
###begin article-title 122
Angiogenesis: update 2005.
###end article-title 122
###begin article-title 123
Matrix molecule interactions with hematopoietic stem cells.
###end article-title 123
###begin article-title 124
Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.
###end article-title 124
###begin article-title 125
###xml 99 104 <span type="species:ncbi:9606">human</span>
Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells.
###end article-title 125
###begin article-title 126
Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature.
###end article-title 126
###begin article-title 127
A reevaluation of integrins as regulators of angiogenesis.
###end article-title 127
###begin article-title 128
Get a ligand, get a life: integrins, signaling and cell survival.
###end article-title 128
###begin article-title 129
Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
###end article-title 129
###begin article-title 130
Microarray analysis of in vitro pericyte differentiation reveals an angiogenic program of gene expression.
###end article-title 130
###begin article-title 131
Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist.
###end article-title 131
###begin article-title 132
Developmental regulation of beta1 integrins during angiogenesis in the central nervous system.
###end article-title 132
###begin article-title 133
Transient functional expression of alphaVbeta 3 on vascular cells during wound repair.
###end article-title 133
###begin article-title 134
###xml 36 41 <span type="species:ncbi:9606">human</span>
Characterization of first trimester human fetal placental vessels using immunocytochemical markers.
###end article-title 134
###begin article-title 135
Distinct patterns of microvascular endothelial cell morphology are determined by extracellular matrix composition.
###end article-title 135
###begin article-title 136
Requirement of vascular integrin alpha v beta 3 for angiogenesis.
###end article-title 136
###begin article-title 137
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin.
###end article-title 137
###begin article-title 138
Beta 1 integrin is essential for teratoma growth and angiogenesis.
###end article-title 138
###begin article-title 139
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins.
###end article-title 139
###begin article-title 140
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
###end article-title 140
###begin article-title 141
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.
###end article-title 141
###begin article-title 142
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice.
###end article-title 142
###begin article-title 143
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model.
###end article-title 143
###begin article-title 144
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 86 89 <span type="species:ncbi:10116">rat</span>
Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke.
###end article-title 144
###begin article-title 145
Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.
###end article-title 145
###begin article-title 146
###xml 45 50 <span type="species:ncbi:9606">human</span>
A potential pro-angiogenic cell therapy with human placenta-derived mesenchymal cells.
###end article-title 146
###begin p 147
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 147
###begin p 148
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: National Science Council (NSC-96-2314-B-195-012-MY2 to C.-P Chen) and Mackay Memorial Hospital (MMH-E 97001 to C.-P. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 148

